Science 37 Holdings Stock Fundamentals
SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Science 37 Holdings fundamentals help investors to digest information that contributes to Science 37's financial success or failures. It also enables traders to predict the movement of Science Stock. The fundamental analysis module provides a way to measure Science 37's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Science 37 stock.
Science |
Science 37 Holdings Company Return On Equity Analysis
Science 37's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Science 37 Return On Equity | -1.19 |
Most of Science 37's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Science 37 Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Science 37 Holdings has a Return On Equity of -1.1852. This is 95.06% lower than that of the Health Care Equipment & Supplies sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
Science 37 Holdings Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Science 37's current stock value. Our valuation model uses many indicators to compare Science 37 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Science 37 competition to find correlations between indicators driving Science 37's intrinsic value. More Info.Science 37 Holdings is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Science 37 by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Science Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Science 37's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Science 37 could also be used in its relative valuation, which is a method of valuing Science 37 by comparing valuation metrics of similar companies.Science 37 is currently under evaluation in return on equity category among its peers.
Science Fundamentals
Return On Equity | -1.19 | |||
Return On Asset | -0.28 | |||
Profit Margin | (2.07) % | |||
Operating Margin | (0.60) % | |||
Current Valuation | (21.22 M) | |||
Shares Outstanding | 6.03 M | |||
Shares Owned By Insiders | 16.89 % | |||
Shares Owned By Institutions | 52.18 % | |||
Number Of Shares Shorted | 13.83 K | |||
Price To Book | 0.67 X | |||
Price To Sales | 0.58 X | |||
Revenue | 60.26 M | |||
Gross Profit | 20.07 M | |||
EBITDA | (59.86 M) | |||
Net Income | (124.65 M) | |||
Cash And Equivalents | 130.24 M | |||
Cash Per Share | 1.12 X | |||
Total Debt | 1.32 M | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 6.32 X | |||
Book Value Per Share | 8.69 X | |||
Cash Flow From Operations | (48.19 M) | |||
Short Ratio | 0.22 X | |||
Earnings Per Share | (21.40) X | |||
Target Price | 13.83 | |||
Number Of Employees | 460 | |||
Beta | 0.56 | |||
Market Capitalization | 34.66 M | |||
Total Asset | 126.45 M | |||
Retained Earnings | (253.07 M) | |||
Working Capital | 103.03 M | |||
Z Score | 12.82 | |||
Net Asset | 126.45 M |
About Science 37 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Science 37 Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Science 37 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Science 37 Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Science 37 Holdings, Inc. provides technology-based solutions to enable agile clinical trials and decentralized approaches. Science 37 Holdings, Inc. was founded in 2014 and is based in Research Triangle Park, North Carolina. Science 37 operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 601 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
Stocks Directory Find actively traded stocks across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Transaction History View history of all your transactions and understand their impact on performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |